Mitochondrial Translocase Expression Profile in Renal Cancer | ||||
| The Egyptian Journal of Hospital Medicine | ||||
| Article 16, Volume 70, Issue 6, January 2018, Page 974-979 PDF (491.97 K) | ||||
| Document Type: Original Article | ||||
| DOI: 10.12816/0044346 | ||||
 View on SCiNiTO | ||||
| Authors | ||||
Belal Ahmed Soliman1; Mohamed Hassany Ali  1; Eman Ali Toraih2; Mohamed Abdelhamid Hasan Ahmed3
| ||||
| 1Department of Zoology, Faculty of Science, Suez Canal University | ||||
| 22 Department of Histology and Genetics, Faculty of Medicine, Suez Canal University | ||||
| 3Department of Pathology, Faculty of Medicine, Suez Canal University | ||||
| Abstract | ||||
| Background: mitochondrial appropriate function depends on ideal mitochondrial translocation machinery, of which translocase of outer mitochondrial membrane (TOMM) have a vital role in normal functioning cell. Any disturbance in the translocation machinery leads to either tumorigenesis or apoptosis. Aim of the work: This study aimed to investigate the expression of TOMM34 in renal cell carcinoma (RCC). TOMM34 expression was assessed in 42 samples of RCC patients using immunohistochemistry technique. Results: immunohistochemical staining revealed significant accumulation of TOMM34 protein in RCC cases compared to their corresponding non-cancerous renal tissues. TOMM34 protein expression was significantly associated with age and gender categories in contrast to the other clinicopathological features. Conclusion: according to protein expression level this study demonstrated that TOMM34 is a marker of poor outcome in RCC. | ||||
| Keywords | ||||
| RCC; TOMM34; IHC | ||||
|
Statistics Article View: 113 PDF Download: 208 |
||||
